Cannabis compound may help frontline health workers avoid COVID-19 burnout

Embargoed until: Publicly released: 2021-08-14 01:00

International

Cannabidiol (CBD), a cannabis component now widely used for medical purposes, could help reduce symptoms of burnout and emotional exhaustion in frontline health care workers during the COVID-19 pandemic. Brazilian researchers found that the treatment helped reduce exhaustion and burnout, however it also resulted in severe side effects in around 1 in 20 of the treatment group. The authors say it is necessary to balance the benefits of CBD therapy with potential undesired or adverse effects, and further studies are needed.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: University of São Paulo, Brazil

Funder: This work was supported by grant 2020/12110-9 from the Fundação de Amparo à Pesquisa do Estado de São Paulo; grant 2008/09009-2 from the Instituto Nacional de Ciência e Tecnologia Translational em Medicina; a grant from the Global Priorities in Cannabinoid Research Excellence Program, University Global Partnership Network (Dr Crippa); funding via research fellowships from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (Drs Crippa, Hallak, de Lima Osório, Loureiro, Campos, and Zuardi); in-kind donations of cannabidiol from PurMed Global; and donated services (dosing plasma levels of cannabidiol) from Laboratório Chromatox. See paper for author conflict of interest statments

Media Contact/s

Contact details are only visible to registered journalists.